Skip to content

Diagnostic accuracy of low dose polyethylene glycol (PEG) based fecal tagging computed tomography colonography (CTC) for the detection of colorectal neoplasia in patients with positive fecal immunochemical test

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000006665
Enrollment
300
Registered
2011-11-04
Start date
2011-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer, colorectal polyp

Interventions

Sponsors

Department od Medical Division of Radiology, Jichi Medical University
Lead Sponsor
1. Otaru Kyokai Hospital 2. Hokkaido Gastroenterology Hospital 3. Tonan Hospital 4. Kameda Medical Center Makuhari 5. Kameda General Hospital 6. Matsuda Hospital 7. Kamigoto Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) fecal immunochemical test positive. 2) Major functions of organs of the subjects are in a good condition. 3) Aged 40 years or older. 4) Signed informed consent forms are obtained by the patients.

Exclusion criteria

Exclusion criteria: 1) Known colorectal polyps or cancers at any site at the time of enrollment. 2) Patients with inflammatory bowel disease. 3) Fulfillment of clinical criteria for diagnosis of FAP or HNPCC (Amsterdam criteria). 4) Serious medical conditions that may increase the risk of optical colonoscopy or are so severe that screening would have no benefit. 5) Previous colorectal surgery. 6) Gastric or intestinal stenosis, abdominal adhesions, bowel obstruction or perforation, toxic megacolon. 7) Evidence of an increased risk in carrying out bowel preparation or CTC exams. 8) Possibility of pregnancy. 9) Optical colonoscopy or barium enema carried out within the last 3 years. 10) Patients with psychological conditions that contraindicate colonoscopy or make them irrelevant to participate in the trial. 11) Claustrophobia. 12) Iodine hypersensitivity. 13) Severe thyroid disease. 14) Severe deafness. 15) Subjects whose eligibility for this clinical trial is not appropriate by other reasons.

Design outcomes

Primary

MeasureTime frame
Low dose polyethylene glycol (PEG) based fecal tagging CTC vs. optical colonoscopy. Detection performance and accuracy of colorectal polyps (at least 6 mm in diameter) and colorectal cancer.

Secondary

MeasureTime frame
Comparative adherence of patients to CTC and optical colonoscopy. Frequency and nature of any adverse events.

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026